Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy
- Resource Type
- Article
- Source
- In
ESMO Open February 2022 7(1) - Subject
Genitourinary Cancers - Language
- ISSN
- 2059-7029